These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8477802)

  • 21. Suppressive effect of a traditional Japanese medicine, Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan), on the hyperresponsiveness to IL-18 in autoimmune MRL/MPJ-lpr/lpr mice.
    Furuya Y; Kawakita T; Nomoto K
    Int Immunopharmacol; 2003 Mar; 3(3):365-73. PubMed ID: 12639814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
    J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of interleukin-6 and the interleukin-6 receptor on glucose transport in mouse skeletal muscle.
    Gray SR; Ratkevicius A; Wackerhage H; Coats P; Nimmo MA
    Exp Physiol; 2009 Aug; 94(8):899-905. PubMed ID: 19482899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
    J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
    Miyawaki S; Nakamura Y; Takeshita T; Yoshida H; Shibata Y; Mitsuoka S
    Lab Anim Sci; 1988 Jun; 38(3):266-72. PubMed ID: 2970562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice.
    Mieza MA; Itoh T; Cui JQ; Makino Y; Kawano T; Tsuchida K; Koike T; Shirai T; Yagita H; Matsuzawa A; Koseki H; Taniguchi M
    J Immunol; 1996 May; 156(10):4035-40. PubMed ID: 8621946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum soluble MD-1 levels increase with disease progression in autoimmune prone MRL(lpr/lpr) mice.
    Sasaki S; Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Tsuneyama K; Hirai Y; Takatsu K
    Mol Immunol; 2012 Jan; 49(4):611-20. PubMed ID: 22118968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder.
    Mehra R; Storfer-Isser A; Kirchner HL; Johnson N; Jenny N; Tracy RP; Redline S
    Arch Intern Med; 2006 Sep; 166(16):1725-31. PubMed ID: 16983050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Soluble interleukin-6 receptors in the serum in multiple myeloma].
    Scudla V; Kubalová D; Bacovský J; Lukes J; Vavrdová V
    Cas Lek Cesk; 1996 Nov; 135(22):719-22. PubMed ID: 8998823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis.
    Yoshida S; Harada T; Iwabe T; Taniguchi F; Mitsunari M; Yamauchi N; Deura I; Horie S; Terakawa N
    Hum Reprod; 2004 Aug; 19(8):1821-5. PubMed ID: 15166129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.
    Pulsatelli L; Boiardi L; Pignotti E; Dolzani P; Silvestri T; Macchioni P; Cantini F; Salvarani C; Facchini A; Meliconi R
    Arthritis Rheum; 2008 Aug; 59(8):1147-54. PubMed ID: 18668607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
    Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
    Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous development of corneal crystalline deposits in MRL/Mp mice.
    Verhagen C; Rowshani T; Willekens B; van Haeringen NJ
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):454-61. PubMed ID: 7843914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BXSB/MpJ-Yaa mice develop autoimmune dacryoadenitis with the appearance of inflammatory cell marker messenger RNAs in the lacrimal fluid.
    Kosenda K; Ichii O; Otsuka S; Hashimoto Y; Kon Y
    Clin Exp Ophthalmol; 2013 Nov; 41(8):788-97. PubMed ID: 23433092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.
    Ikeda K; Kinoshita M; Tagaya N; Shiojima T; Taga T; Yasukawa K; Suzuki H; Okano A
    Brain Res; 1996 Jul; 726(1-2):91-7. PubMed ID: 8836549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
    Tamura T; Udagawa N; Takahashi N; Miyaura C; Tanaka S; Yamada Y; Koishihara Y; Ohsugi Y; Kumaki K; Taga T
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11924-8. PubMed ID: 8265649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.
    Rudofsky UH; Dilwith RL; Roths JB; Lawrence DA; Kelley VE; Magro AM
    Am J Pathol; 1984 Jul; 116(1):107-14. PubMed ID: 6377906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
    Horiuchi S; Ampofo W; Koyanagi Y; Yamashita A; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
    Immunology; 1998 Nov; 95(3):360-9. PubMed ID: 9824498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.